NEW YORK (GenomeWeb) — Natera's SNP-based non-invasive prenatal Panorama test can detect unrecognized twin pregnancies, including vanishing twins, and fetal triploidy in women undergoing routine prenatal screening, according to a recent study by researchers at Natera and a collaborator at Brigham and Women's Hospital in Boston. The ability to identify vanishing twins and triploid pregnancies could lower the rate of false-positive results from NIPT, prevent incorrect calls on fetal sex, and help with clinical management of triploid pregnancies, Natera said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.